This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03408/identifier/chebi/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n5http://linked.opendata.cz/resource/drugbank/drug/DB03408/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB03408/identifier/kegg-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03408/identifier/pubchem-compound/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n15http://linked.opendata.cz/resource/drugbank/drug/DB03408/identifier/pubchem-substance/
n8http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/property/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03408/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03408
rdf:type
n8:Drug
n8:group
experimental
owl:sameAs
n11:DB03408 n12:DB03408
dcterms:title
Gamma-Glutamylcysteine
adms:identifier
n4:C00669 n5:3GC n6:17515 n7:DB03408 n14:13922647 n15:46506032
n8:synthesisReference
Hiroaki Nishiuchi, "Method for producing gamma-glutamylcysteine." U.S. Patent US20030124684, issued July 03, 2003.
n8:IUPAC-Name
n9:271B453D-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B4543-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B4542-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B453F-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B4540-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B4541-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B453B-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B4539-363D-11E5-9242-09173F13E4C5 n9:271B453C-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B453A-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B4549-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B454A-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B4544-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B4545-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B4547-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B4546-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B4548-363D-11E5-9242-09173F13E4C5
n8:casRegistryNumber
686-58-8
n8:Bioavailability
n9:271B454F-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B4551-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B4552-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B454E-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B454D-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B4550-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B453E-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B454B-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B454C-363D-11E5-9242-09173F13E4C5